LGVN — Longeveron LLC · rev $2.4M

Longeveron LLC (LGVN) is a biotechnology company listed on NASDAQ.

Latest reported LGVN revenue for 2024-12-31 was $2.4M. Net income was -$16.0M. Revenue was up 237.4% from 2023-12-31 to 2024-12-31. LGVN currently screens at market cap $26.5M.

Use this LGVN page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the LGVN quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the LGVN SEC filings page. Lician reads the product cache first so this HTML stays unique to Longeveron LLC even when a live quote feed is slow.

Longeveron LLC latest statements (FY2024)

Latest cached year on this hub. Full LGVN income, balance, and cash tables.

  • Revenue$2.4M
  • Net Income-$16.0M
  • Total Assets$10.3M
  • Total Debt$0
  • Free Cash Flow$0

LGVN recent filings